|
Home : Unsafe Drugs : Avandia : News Articles : GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations - Seeking Alpha GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations - Seeking Alpha
aside $3.4 billion to pay for a federal investigation in the United States and product liability cases over its marketing of the diabetes drug Avandia. The set aside is expected to wipe out fourth quarter profits for the drug giant. In July 2010, the ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




